Targeting HDAC6 to treat heart failure with preserved ejection fraction in miceSara Ranjbarvaziri, Jin Yang, Cindy Li et al.|Nature Communications|2024Cited by 50
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy modelsAmara Greer-Short, Laura M. Lombardi, Kathryn N. Ivey et al.|Nature Communications|2025Cited by 32
Author Correction: Targeting HDAC6 to treat heart failure with preserved ejection fraction in miceSara Ranjbarvaziri, Jin Yang, Emma Xu et al.|Nature Communications|2024Cited by 3